Trial · NCT06273397
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Treatment success | 4 days | Complete decongestion by the third morning without requiring escalation in diuretic therapy (by the second morning). |
| Secondary | Mortality | 3 months | All-cause mortality during the first 3 months after start of the study |
| Secondary | Worsening Heart Failure | 3 months | Readmission for Heart Failure or Urgent visit for Heart Failure during the first 3 months after start of the study |
| Secondary | Cumulative 24-hour Natriuresis | Day 2 | Natriuresis measured on the second day |
| Secondary | Cumulative weight loss | 4 days | Cumulative weight loss by the third morning |
| Secondary | Subclinical congestion | 4 days | Congestion score will be the score used in the study to evaluate the primary outcome. The calculated scores can range from 0 to 12 points, with 0 indicating absence of congestion and 12 representing the highest degree of congestion. The primary outcome will be defined as achieving a score of 0 or 1 and also having absence of B-lines in the lung ultrasound (negative LUS criterion). In this secondary outcome, the presence of subclinical congestion will be evaluated, which is defined as a congestion score of 0 or 1 but with a positive LUS. |
| Secondary | Change in Hematocrit value | 4 days | Change in Hematocrit |
| Secondary | Change in NT-proBNP concentration | 4 days | Change in NT-proBNP |
| Secondary | Change in CA125 value | 4 days | Change in CA125 |
| Other | Any adverse event | 3 months | Any adverse clinical event related to intervention during the first 3 months after start of the study |
| Other | Changes in pH value | 4 days | Change in pH over the specified time period |
| Other | Change in plasma electrolyte values | 4 days | Change in plasma concentration of sodium, potassium, and chloride |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06273397/registered